SPRUCE BIOSCIENCES, INC., 2025-10-17
An SEC Form D private-offering notice from South San Francisco, CA, a $49,999,768 filer-stated offering target in Biotech. Filed 2025-10-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing therapies for neurological and endocrine disorders, including an enzyme replacement therapy for MPS IIIB (Sanfilippo Syndrome Type B).
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Bloc Wines, Inc., 2025-10-17, Napa, CA
- Vergent Bioscience, Inc., 2025-10-20, $32M, Minneapolis, MN
- Sleuth Insights, Inc., 2025-10-17, $7.9M, San Francisco, CA
- Cleveland Diagnostics, Inc., 2025-10-20, $14.4M, Cleveland, OH
- Intangible Technology Inc., 2025-10-17, $2M, San Francisco, CA
- Tidal Diagnostic Solutions Inc., 2025-10-17, $300K, Scarborough, ME
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.